Stay updated on Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.

Latest updates to the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 appears on the page, replacing the previous v3.3.3. This update likely reflects an updated study document version.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedExpanded study locations across the United States, Canada, and Europe, with a reorganization of site information and removal of the HHS Vulnerability Disclosure section. A new revision tag (v3.3.3) is shown on the page.SummaryDifference2%

- Check52 days agoChange DetectedPage revision updated to v3.3.2; the previous revision v3.3.1 was removed.SummaryDifference0.0%

- Check59 days agoChange DetectedPublications section now notes that PubMed publications are automatically filled and may not be about the study, and the revision identifier has been updated to v3.3.1 (replacing v3.2.0).SummaryDifference0.7%

- Check67 days agoChange DetectedThe government funding lapse disclaimer was removed from the page, removing guidance about potential data inaccuracy and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedThe Locations section was updated to add and remove study sites across several countries. Enrollment options and site accessibility may be affected.SummaryDifference0.3%

Stay in the know with updates to Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.